More recently, a study demonstrated that HPVneg HNSCC cancer cells harboring a mesenchymal phenotype were less sensitive to CDK4/6 inhibition than those with an epithelial phenotype [8]. The gene discussed is CDK4; the disease is head and neck squamous cell carcinoma.